Twice-daily deucravacitinib 3 mg and 6 mg significantly improved cutaneous lupus erythematosus activity by week 16, according ...
The Little Lehigh Watershed Stewards are calling attention to how long rock salt sticks around in local streams and drinking ...
Goldberg Segalla added Thomas Schoendorf to the firm’s product liability and civil litigation and trial practice groups in ...
2d
Study Finds on MSNThis simple tasty snack swap can protect you from heart diseaseBoost your heart health with simple snacks. Discover how pecans can be your go-to choice for better heart health and ...
1d
MyChesCo on MSNOcugen Advances OCU200 Clinical Trial Amid Promising Safety ResultsMALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced progress in its Phase 1 clinical trial for OCU200, a novel biologic ...
In addition to comparable BCVA levels, the researchers concluded that the PDS implant “provides effective, durable, and ...
Sirolimus, the active ingredient in Felycin-CA1, at a higher dose is used as an immunosuppressant in human patients receiving ...
BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...
For Dominick Dunlap's family, the risks of blood clots associated with feminizing hormone therapy appear to have led to ...
A Philadelphia man is facing drug charges after a Saturday traffic stop in Marple uncovered narcotics and drug paraphernalia ...
Adding an anti-obesity medication just one month after behavioral therapy begins—rather than waiting the currently ...
Intermittent fasting appears to help stop platelet activation and clot formation, which could help decrease the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results